Neurosense Therapeutics Ltd

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.10

-1.85 (-26.62%)

As of Sep 28, 10:34 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +590.8% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $5.10

Current
$5.10

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

445.9%

Low target

Base Case

$35.23

+590.8%

Avg target

Bull Case

$57.14

+1,020.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$26.64

-80.9% from high

52-Week Low

$5.00

+2.0% from low

Target vs 52W High

$35.23

+32.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%